Skip to main content
syn
Daily Digest
Science & Health

AIIMS establishes advanced facility for epilepsy patients

Published Sunday, May 10, 2026 · Updated May 11

Share on X

Source Balance

Mostly Balanced
Left 50%Center 50%Right 0%

Coverage is limited to a single source, potentially lacking diverse perspectives.

Media Analysis

AI synthesis

AIIMS Delhi's Neurobiochemistry Laboratory at the Neurosciences Centre has launched an advanced Therapeutic Drug Monitoring (TDM) facility for epilepsy patients. This facility aims to provide affordable, high-quality care, optimize drug dosages, and minimize side effects, particularly benefiting economically underprivileged patients.

What We Know — Key Points

  • The Neurobiochemistry Laboratory at the Neurosciences Centre (NSC) of All India Institute of Medical Sciences (AIIMS), Delhi, has launched an advanced Therapeutic Drug Monitoring (TDM) facility for epilepsy patients.
  • The new TDM facility aims to provide affordable, high-quality care and relief to economically underprivileged epilepsy patients.
  • The TDM facility will help in optimizing drug dosages and minimizing side effects for epilepsy patients.

What Is Claimed — Perspectives

  • The HinduCenter-Left

    The article emphasizes the facility's role in providing affordable, high-quality care and relief to economically underprivileged patients.

AI-Generated Content

  • This topic was generated by an AI system.
  • Key points, perspectives, bias labels, and categorisation may contain errors.
  • This is not journalism. Do not rely on this content for critical decisions.
  • Read our full AI disclaimer for details.